{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T09:10:02Z","timestamp":1785316202803,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ezat Hesni","award":["123"],"award-info":[{"award-number":["123"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Since the first official report of SARS-CoV-2 infection in Iran on 19 February 2020, our country has been one of the worst affected countries by the COVID-19 epidemic in the Middle East. In addition to demographic and clinical characteristics, the number of hospitalized cases and deaths is an important factor for evidence-based decision-making and disease control and preparing the healthcare system to face the future challenges of COVID-19. Therefore, this cohort study was conducted to determine the demographics, clinical characteristics, and outcomes of hospitalized COVID-19 patients in Kermanshah Province, west of Iran.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This multicenter retrospective cohort study included all suspected, probable, and confirmed cases of COVID-19 hospitalized in Kermanshah Province, Iran during the first year of the COVID-19 pandemic. Demographics, clinical characteristics, outcomes and other additional information of hospitalized patients were collected from the COVID-19 database of the Medical Care Monitoring Center (MCMC) of Kermanshah Province.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Kermanshah Province experienced three waves of COVID-19 infection considering the hospitalization and mortality rates between February 20, 2020 and February 19, 2021. A total of 27,256 patients were included in the study: 5203 (19.09%) subjects were suspected, 9136(33.52%) were probable, and 12,917 (47.39%) were confirmed COVID-19 cases. The mean age of the patients was 53.34\u2009\u00b1\u200922.74\u00a0years and 14,648 (53.74%) were male. The median length of hospital stay among COVID-19 survivors and non-survivors patients were 4 (interquartile range [IQR] 1\u20136) and 4 (IQR 1\u20138) days, respectively. Among patients with COVID-19, 2646 (9.71%) died during hospitalization. A multivariable logistic regression revealed that odds of death among patients\u2009\u2265\u200985\u00a0years was significantly greater than among patients\u2009&lt;\u200915\u00a0years (adjusted odds ratio [aOR] 4.79, 95% confidence interval [CI]\u2009=\u20093.43\u20136.71, p\u2264\u20090.001). Patients with one (aOR 1.38, 95% CI 1.21\u20131.59, p\u2009=\u20090.04), two (aOR 1.56, 95% CI 1.27\u20131.92, p\u2009=\u20090.001) or more (aOR 1.50, 95% CI 1.04\u20132.17, p\u2009=\u20090.03) comorbidities had higher odds of in-hospital death compared to those without comorbidities. The male sex (aOR 1.20, 95% CI 1.07- 1.35, p\u2009=\u20090.002), ICU admission (aOR 4.35, 95% CI 3.80\u20134.97, p\u2009&lt;\u20090.001), intubation (aOR 11.09, 95% CI 9.58\u201312.84, p\u2009&lt;\u20090.001), respiratory distress (aOR 1.40, 95% CI 1.22\u20131.61, p\u2009&lt;\u20090.001), loss of consciousness (aOR 1.81, 95% CI 1.45\u20132.25, p\u2009&lt;\u20090.001), anorexia (aOR 1.36, 95% CI 1.09\u20131.70, p\u2009=\u20090.006) and peripheral oxygen saturation (SpO2)\u2009&lt;\u200993(aOR 2.72, 95% CI 2.34\u20133.16, p\u2009&lt;\u20090.001) on admission were associated with increased risk of death in patients with SARS-CoV-2 infection. Having cough (aOR 0.82, 95% CI 0.72\u20130.93, p\u2009=\u20090.003) and headache (aOR 0.70, 95% CI 0.50\u20130.97, p\u2009=\u20090.03) decreased the odds of death.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The mortality rate of the patients admitted to the general wards and ICU can be a guide for allocating resources and making appropriate plans to provide better medical interventions during the COVID-19 pandemic. Several risk factors are associated with the in-hospital mortality of COVID-19, including advanced age, male sex, ICU admission, intubation, having comorbidity, SpO2\u2009&lt;\u200993, respiratory distress, loss of consciousness, headache, anorexia, and cough. These risk factors could help clinicians identify patients at high risk for death.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07312-7","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T14:03:46Z","timestamp":1648735426000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Demographics, clinical characteristics, and outcomes of 27,256 hospitalized COVID-19 patients in Kermanshah Province, Iran: a retrospective one-year cohort study"],"prefix":"10.1186","volume":"22","author":[{"given":"Ezat","family":"Hesni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak","family":"Sayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Khosravi Shadmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid","family":"Najafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Khodarahmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohreh","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arezoo","family":"Bozorgomid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin","family":"Sayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,31]]},"reference":[{"key":"7312_CR1","doi-asserted-by":"publisher","DOI":"10.15557\/PiMR.2020.0003","volume-title":"Clinical management of severe acute respiratory infection ( SARI) when COVID-19 disease is suspected: interim guidance, 13 March 2020","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. Clinical management of severe acute respiratory infection ( SARI) when COVID-19 disease is suspected: interim guidance, 13 March 2020. Geneva: World Health Organization; 2020."},{"issue":"8","key":"7312_CR2","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.3390\/ijerph18084350","volume":"18","author":"A Sis\u00f3-Almirall","year":"2021","unstructured":"Sis\u00f3-Almirall A, Brito-Zer\u00f3n P, Conangla Ferr\u00edn L, Kostov B, Moragas Moreno A, Mestres J, et al. Long COVID-19: proposed primary care clinical guidelines for diagnosis and disease management. Int J Environ Res Public Health. 2021;18(8):4350.","journal-title":"Int J Environ Res Public Health"},{"issue":"6500","key":"7312_CR3","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1126\/science.abc3517","volume":"369","author":"H Salje","year":"2020","unstructured":"Salje H, Tran Kiem C, Lefrancq N, Courtejoie N, Bosetti P, Paireau J, et al. Estimating the burden of SARS-CoV-2 in France. Science. 2020;369(6500):208\u201311.","journal-title":"Science"},{"key":"7312_CR4","doi-asserted-by":"crossref","unstructured":"Avatef Fazeli M, Rezaei L, Javadirad E, Iranfar K, Khosravi A, Amini Saman J, et al. Increased incidence of rhino-orbital mucormycosis in an educational therapeutic hospital during the COVID-19 pandemic in western Iran: An observational study. Mycoses. 2021;64(11):1366\u201377.","DOI":"10.1111\/myc.13351"},{"issue":"8","key":"7312_CR5","first-page":"1564","volume":"49","author":"J Yavarian","year":"2020","unstructured":"Yavarian J, Shafiei-Jandaghi N-Z, Sadeghi K, Malekshahi SS, Salimi V, Nejati A, et al. First cases of SARS-CoV-2 in Iran, 2020: case series report. Iran J Public Health. 2020;49(8):1564.","journal-title":"Iran J Public Health"},{"issue":"4","key":"7312_CR6","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S1473-3099(20)30858-6","volume":"21","author":"H Poustchi","year":"2021","unstructured":"Poustchi H, Darvishian M, Mohammadi Z, Shayanrad A, Delavari A, Bahadorimonfared A, et al. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study. Lancet Infect Dis. 2021;21(4):473\u201381.","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"7312_CR7","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1017\/ice.2020.169","volume":"41","author":"N Mohammadzadeh","year":"2020","unstructured":"Mohammadzadeh N, Shahriary M, Nasri E. Iran\u2019s success in controlling the COVID-19 pandemic. Infect Control Hosp Epidemiol. 2020;41(11):1359\u201360.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"7312_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkab152","author":"B Sayad","year":"2021","unstructured":"Sayad B, Khodarahmi R, Najafi F, Miladi R, Afshar ZM, Mansouri F, et al. Efficacy and safety of sofosbuvir\/velpatasvir versus the standard of care in adults hospitalized with COVID-19: a single-centre, randomized controlled trial. J Antimicrob Chemother. 2021. https:\/\/doi.org\/10.1093\/jac\/dkab152.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"7312_CR9","doi-asserted-by":"publisher","first-page":"e213984","DOI":"10.1001\/jamanetworkopen.2021.3984","volume":"4","author":"RF Schoeni","year":"2021","unstructured":"Schoeni RF, Wiemers EE, Seltzer JA, Langa KM. Association between risk factors for complications from COVID-19, perceived chances of infection and complications, and protective behavior in the US. JAMA Netw Open. 2021;4(3):e213984.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"7312_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S2213-2600(20)30527-0","volume":"9","author":"L Piroth","year":"2021","unstructured":"Piroth L, Cottenet J, Mariet A-S, Bonniaud P, Blot M, Tubert-Bitter P, et al. Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study. Lancet Respir Med. 2021;9(3):251\u20139.","journal-title":"Lancet Respir Med"},{"key":"7312_CR11","doi-asserted-by":"publisher","first-page":"100096","DOI":"10.1016\/j.lanepe.2021.100096","volume":"4","author":"S Yegorov","year":"2021","unstructured":"Yegorov S, Goremykina M, Ivanova R, Good SV, Babenko D, Shevtsov A, et al. Epidemiology, clinical characteristics, and virologic features of COVID-19 patients in Kazakhstan: a nation-wide retrospective cohort study. Lancet Reg Health-Eur. 2021;4:100096.","journal-title":"Lancet Reg Health-Eur."},{"key":"7312_CR12","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2021.36.e12","author":"S-W Kim","year":"2021","unstructured":"Kim S-W, Kim S-M, Kim YK, Kim J-Y, Lee Y-M, Kim B-O, et al. Clinical characteristics and outcomes of COVID-19 cohort patients in Daegu metropolitan city outbreak in 2020. J Korean Med Sci. 2021. https:\/\/doi.org\/10.3346\/jkms.2021.36.e12.","journal-title":"J Korean Med Sci"},{"key":"7312_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.01.019","author":"MS Marcolino","year":"2021","unstructured":"Marcolino MS, Ziegelmann PK, Souza-Silva MV, Nascimento I, Oliveira LM, Monteiro LS, et al. Clinical characteristics and outcomes of patients hospitalized with COVID-19 in Brazil: Results from the Brazilian COVID-19 registry. Int J Infect Dis. 2021. https:\/\/doi.org\/10.1016\/j.ijid.2021.01.019.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"7312_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12873-021-00463-x","volume":"21","author":"D Adham","year":"2021","unstructured":"Adham D, Habibzadeh S, Ghobadi H, Jajin SA, Abbasi-Ghahramanloo A, Moradi-Asl E. Epidemiological characteristics and mortality risk factors among COVID-19 patients in Ardabil, Northwest of Iran. BMC Emerg Med. 2021;21(1):1\u20136.","journal-title":"BMC Emerg Med"},{"issue":"1","key":"7312_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-020-05706-z","volume":"21","author":"L Goshayeshi","year":"2021","unstructured":"Goshayeshi L, Akbari Rad M, Bergquist R, Allahyari A, Hashemzadeh K, Hoseini B. Demographic and clinical characteristics of severe Covid-19 infections: a cross-sectional study from Mashhad University of Medical Sciences. Iran BMC infectious diseases. 2021;21(1):1\u20138.","journal-title":"Iran BMC infectious diseases"},{"issue":"1","key":"7312_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.7326\/M20-2911","volume":"174","author":"M Jalili","year":"2021","unstructured":"Jalili M, Payandemehr P, Saghaei A, Sari HN, Safikhani H, Kolivand P. Characteristics and mortality of hospitalized patients with COVID-19 in Iran: a National Retrospective Cohort Study. Ann Intern Med. 2021;174(1):125\u20137.","journal-title":"Ann Intern Med"},{"issue":"4","key":"7312_CR17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S2213-2600(20)30560-9","volume":"9","author":"OT Ranzani","year":"2021","unstructured":"Ranzani OT, Bastos LS, Gelli JGM, Marchesi JF, Bai\u00e3o F, Hamacher S, et al. Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data. Lancet Respir Med. 2021;9(4):407\u201318.","journal-title":"Lancet Respir Med"},{"issue":"10","key":"7312_CR18","doi-asserted-by":"publisher","first-page":"e558","DOI":"10.1093\/cid\/ciaa1268","volume":"72","author":"MW Fried","year":"2021","unstructured":"Fried MW, Crawford JM, Mospan AR, Watkins SE, Munoz B, Zink RC, et al. Patient characteristics and outcomes of 11 721 patients with coronavirus disease 2019 (COVID-19) hospitalized across the United States. Clin Infect Dis. 2021;72(10):e558\u201365.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"7312_CR19","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.jiph.2021.03.016","volume":"14","author":"F Khamis","year":"2021","unstructured":"Khamis F, Memish Z, Al Bahrani M, Al Dowaiki S, Pandak N, Al Bolushi Z, et al. Prevalence and predictors of in-hospital mortality of patients hospitalized with COVID-19 infection. J Infect Public Health. 2021;14(6):759\u201365.","journal-title":"J Infect Public Health"},{"issue":"7","key":"7312_CR20","doi-asserted-by":"publisher","first-page":"4553","DOI":"10.1002\/jmv.26956","volume":"93","author":"V Malhotra","year":"2021","unstructured":"Malhotra V, Basu S, Sharma N, Kumar S, Garg S, Dushyant K, et al. Outcomes among 10,314 hospitalized COVID-19 patients at a tertiary care government hospital in Delhi. India J Med Virol. 2021;93(7):4553\u20138.","journal-title":"India J Med Virol"},{"key":"7312_CR21","doi-asserted-by":"publisher","first-page":"100108","DOI":"10.1016\/j.lanwpc.2021.100108","volume":"9","author":"H Surendra","year":"2021","unstructured":"Surendra H, Elyazar IR, Djaafara BA, Ekawati LL, Saraswati K, Adrian V, et al. Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: a hospital-based retrospective cohort study. Lancet Reg Health Western Pacific. 2021;9:100108.","journal-title":"Lancet Reg Health Western Pacific."},{"issue":"20","key":"7312_CR22","doi-asserted-by":"publisher","first-page":"7560","DOI":"10.3390\/ijerph17207560","volume":"17","author":"C Faes","year":"2020","unstructured":"Faes C, Abrams S, Van Beckhoven D, Meyfroidt G, Vlieghe E, Hens N. Time between symptom onset, hospitalisation and recovery or death: statistical analysis of Belgian COVID-19 patients. Int J Environ Res Public Health. 2020;17(20):7560.","journal-title":"Int J Environ Res Public Health"},{"issue":"8","key":"7312_CR23","doi-asserted-by":"publisher","first-page":"e0255427","DOI":"10.1371\/journal.pone.0255427","volume":"16","author":"C G\u00fcnster","year":"2021","unstructured":"G\u00fcnster C, Busse R, Spoden M, Rombey T, Schillinger G, Hoffmann W, et al. 6-month mortality and readmissions of hospitalized COVID-19 patients: a nationwide cohort study of 8,679 patients in Germany. PLoS ONE. 2021;16(8):e0255427.","journal-title":"PLoS ONE"},{"issue":"1","key":"7312_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-020-05706-z","volume":"21","author":"M-R Sohrabi","year":"2021","unstructured":"Sohrabi M-R, Amin R, Maher A, Bahadorimonfared A, Janbazi S, Hannani K, et al. Sociodemographic determinants and clinical risk factors associated with COVID-19 severity: a cross-sectional analysis of over 200,000 patients in Tehran. Iran BMC Infectious Diseases. 2021;21(1):1\u201313.","journal-title":"Iran BMC Infectious Diseases"},{"issue":"9","key":"7312_CR25","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S2213-2600(20)30316-7","volume":"8","author":"C Karagiannidis","year":"2020","unstructured":"Karagiannidis C, Mostert C, Hentschker C, Voshaar T, Malzahn J, Schillinger G, et al. Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study. Lancet Respir Med. 2020;8(9):853\u201362.","journal-title":"Lancet Respir Med"},{"issue":"10","key":"7312_CR26","doi-asserted-by":"publisher","first-page":"e0239571","DOI":"10.1371\/journal.pone.0239571","volume":"15","author":"A Rodr\u00edguez-Molinero","year":"2020","unstructured":"Rodr\u00edguez-Molinero A, G\u00e1lvez-Barr\u00f3n C, Mi\u00f1arro A, Macho O, L\u00f3pez GF, Robles MT, et al. Association between COVID-19 prognosis and disease presentation, comorbidities and chronic treatment of hospitalized patients. PLoS ONE. 2020;15(10):e0239571.","journal-title":"PLoS ONE"},{"issue":"8","key":"7312_CR27","doi-asserted-by":"publisher","first-page":"100618","DOI":"10.1016\/j.cpcardiol.2020.100618","volume":"45","author":"S Zaim","year":"2020","unstructured":"Zaim S, Chong JH, Sankaranarayanan V, Harky A. COVID-19 and multiorgan response. Curr Prob Cardiol. 2020;45(8):100618.","journal-title":"Curr Prob Cardiol."},{"issue":"1","key":"7312_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12941-020-00412-9","volume":"20","author":"Y Lu","year":"2021","unstructured":"Lu Y, Huang Z, Wang M, Tang K, Wang S, Gao P, et al. Clinical characteristics and predictors of mortality in young adults with severe COVID-19: a retrospective observational study. Ann Clin Microbiol Antimicrob. 2021;20(1):1\u20139.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"2","key":"7312_CR29","first-page":"E298","volume":"62","author":"MR Honarvar","year":"2021","unstructured":"Honarvar MR, Roshandel G, Shirzad-Aski H, Tabarraei A, Tahamtan A, Ghelichi-Ghojogh M, et al. Epidemiological and clinical characteristics of the COVID-19 epidemic and associated factors for mortality in Golestan province, Iran: a retrospective cohort study. J Prev Med Hyg. 2021;62(2):E298.","journal-title":"J Prev Med Hyg"},{"issue":"11","key":"7312_CR30","doi-asserted-by":"publisher","first-page":"e0241824","DOI":"10.1371\/journal.pone.0241824","volume":"15","author":"FK Ho","year":"2020","unstructured":"Ho FK, Petermann-Rocha F, Gray SR, Jani BD, Katikireddi SV, Niedzwiedz CL, et al. Is older age associated with COVID-19 mortality in the absence of other risk factors? General population cohort study of 470,034 participants. PLoS ONE. 2020;15(11):e0241824.","journal-title":"PLoS ONE"},{"issue":"2","key":"7312_CR31","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1016\/j.jinf.2020.04.021","volume":"81","author":"Z Zheng","year":"2020","unstructured":"Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020;81(2):e16\u201325.","journal-title":"J Infect"},{"issue":"1","key":"7312_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-017-4524-0","volume":"18","author":"J-E Park","year":"2018","unstructured":"Park J-E, Jung S, Kim A. MERS transmission and risk factors: a systematic review. BMC Public Health. 2018;18(1):1\u201315.","journal-title":"BMC Public Health"},{"issue":"1","key":"7312_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-79139-8","volume":"11","author":"SI Cho","year":"2021","unstructured":"Cho SI, Yoon S, Lee H-J. Impact of comorbidity burden on mortality in patients with COVID-19 using the Korean health insurance database. Sci Rep. 2021;11(1):1\u20139.","journal-title":"Sci Rep"},{"issue":"1","key":"7312_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-019-4717-5","volume":"20","author":"K van Halem","year":"2020","unstructured":"van Halem K, Bruyndonckx R, van der Hilst J, Cox J, Driesen P, Opsomer M, et al. Risk factors for mortality in hospitalized patients with COVID-19 at the start of the pandemic in Belgium: a retrospective cohort study. BMC Infect Dis. 2020;20(1):1\u201310.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"7312_CR35","doi-asserted-by":"publisher","first-page":"e216556","DOI":"10.1001\/jamanetworkopen.2021.6556","volume":"4","author":"L Finelli","year":"2021","unstructured":"Finelli L, Gupta V, Petigara T, Yu K, Bauer KA, Puzniak LA. Mortality among US patients hospitalized with SARS-CoV-2 infection in 2020. JAMA Netw Open. 2021;4(4):e216556.","journal-title":"JAMA Netw Open"},{"issue":"11","key":"7312_CR36","doi-asserted-by":"publisher","first-page":"e0240781","DOI":"10.1371\/journal.pone.0240781","volume":"15","author":"J Regina","year":"2020","unstructured":"Regina J, Papadimitriou-Olivgeris M, Burger R, Le Pogam M-A, Niemi T, Filippidis P, et al. Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: an observational retrospective study. PLoS ONE. 2020;15(11):e0240781.","journal-title":"PLoS ONE"},{"issue":"7","key":"7312_CR37","doi-asserted-by":"publisher","first-page":"e0254066","DOI":"10.1371\/journal.pone.0254066","volume":"16","author":"NT Nguyen","year":"2021","unstructured":"Nguyen NT, Chinn J, De Ferrante M, Kirby KA, Hohmann SF, Amin A. Male gender is a predictor of higher mortality in hospitalized adults with COVID-19. PLoS ONE. 2021;16(7):e0254066.","journal-title":"PLoS ONE"},{"issue":"1","key":"7312_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13293-020-00330-7","volume":"11","author":"A Pradhan","year":"2020","unstructured":"Pradhan A, Olsson P-E. Sex differences in severity and mortality from COVID-19: are males more vulnerable? Biol Sex Differ. 2020;11(1):1\u201311.","journal-title":"Biol Sex Differ"},{"issue":"3","key":"7312_CR39","doi-asserted-by":"publisher","first-page":"100134","DOI":"10.1016\/j.ajogmf.2020.100134","volume":"2","author":"RA Pierce-Williams","year":"2020","unstructured":"Pierce-Williams RA, Burd J, Felder L, Khoury R, Bernstein PS, Avila K, et al. Clinical course of severe and critical coronavirus disease 2019 in hospitalized pregnancies: a United States cohort study. Am J Obstet Gynecol MFM. 2020;2(3):100134.","journal-title":"Am J Obstet Gynecol MFM."},{"key":"7312_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-020-05889-5","author":"J Chi","year":"2020","unstructured":"Chi J, Gong W, Gao Q. Clinical characteristics and outcomes of pregnant women with COVID-19 and the risk of vertical transmission: a systematic review. Arch Gynecol Obstet. 2020. https:\/\/doi.org\/10.1007\/s00404-020-05889-5.","journal-title":"Arch Gynecol Obstet"},{"key":"7312_CR41","doi-asserted-by":"crossref","unstructured":"Cardona-P\u00e9rez JA, Villegas-Mota I, Helguera-Repetto AC, Acevedo-Gallegos S, Rodr\u00edguez-Bosch M, Aguinaga-R\u00edos M, et al. Prevalence, clinical features, and outcomes of SARS-CoV-2 infection in pregnant women with or without mild\/moderate symptoms: Results from universal screening in a tertiary care center in Mexico City, Mexico. PLoS One. 2021;16(4):e0249584.","DOI":"10.1371\/journal.pone.0249584"},{"issue":"9","key":"7312_CR42","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1017\/ice.2020.152","volume":"41","author":"A Kaffashi","year":"2020","unstructured":"Kaffashi A, Jahani F. Nowruz travelers and the COVID-19 pandemic in Iran. Infect Control Hosp Epidemiol. 2020;41(9):1121.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"7312_CR43","unstructured":"https:\/\/per.euronews.com\/2021\/04\/26\/iran-hit-daily-death-toll-record-amid-pandemic-new-wave. Accessed 26 Apr 2021."},{"key":"7312_CR44","first-page":"661277","volume":"8","author":"Z Fattahi","year":"2021","unstructured":"Fattahi Z, Mohseni M, Beheshtian M, Jafarpour A, Jalalvand K, Keshavarzi F, et al. Disease waves of SARS-CoV-2 in Iran closely mirror global pandemic trends. MedRxiv. 2021;8:661277.","journal-title":"MedRxiv."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07312-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07312-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07312-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:26:23Z","timestamp":1648779983000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07312-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,31]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7312"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07312-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,31]]},"assertion":[{"value":"28 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol was approved by the Ethics Committee of Guilan University of Medical Sciences, code number: IR.GUMS.REC.1399.489. The requirement for informed consent was waived because of the retrospective nature of the study by the Ethics Committee of Guilan University of Medical Sciences. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All the authors declare no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"319"}}